Extracorporeal Shockwave Therapy (ESWT) is a revolutionary technology that involves shockwaves being passed through the skin to the injured part of the body. The shockwaves are made up of compressed air that is passed at high speed from a hand-held applicator. Shockwave Therapy is the most advanced non-surgical and non-invasive treatment available for a wide range of conditions including plantar fasciitis, achilles tendinopathy, hip bursitis, tennis and golfer’s elbow, Osgood Schlatter disease, subacromial shoulder pain and calcific tendonitis of the shoulder. The audible, low energy sound waves work by increasing blood flow to the injured area, stimulating cell regeneration and healing and decreasing local factors which can cause pain.
Shockwave Therapy is administered using the pioneering and globally recognised Swiss Dolorclast unit. A course of FIVE treatments, one week apart, is recommended, with a 8-week review period following the final treatment, to see maximum improvements. This allows the shockwaves to effectively treat the pain centres. The shockwave therapy treatment is administered by one of the Square One specialist therapists who are Academy trained and CPD qualified.
During the initial assessment, the treatment will also be administered. Ultrasound may be used with the shockwave therapy to achieve an overall improvement in treatment outcome.
The Swiss Dolorclast Shockwave Therapy Method
When Shockwave Therapy May Not Be Suitable – Contraindications
While Shockwave Therapy is suitable for a large number of conditions with minimal side effects, there are some conditions, also known as contraindications, that means this treatment is not an option.
Shockwave Therapy is unsuitable in the following circumstances:
- If you are pregnant
- If you have a blood clotting disorder (including thrombosis)
- If you are taking oral anti-coagulants
- If you have received a Steroid injection within 6 weeks
- If you have a pacemaker fitted
- If tumours are present at the treatment site
- If you have an infection or skin abrasion at the treatment site
- If you are Under 18 (except in the treatment of Osgood-Schlatter disease)
- Any treatment over an air-filled area such as the lungs or guts
Shockwave Therapy: NICE Guidelines
The National Institute for Health and Clinical Excellence (NICE) issues guidance on medicines, treatments and procedures. NICE is a special health authority of the National Health Service (NHS).
Read the Nice Guidelines on Extracorporeal Shockwave Therapy here: